tm logo
NEXT DX
REGISTERED

on 19 Jul 2024

Last Applicant/ Owned by

PERSONALIS INC.

1330 O'Brien DriveMenlo Park CA 94025

US

Serial Number

2225463 filed on 27th Oct 2022

Registration Number

TMA1245605 registered on 19th Jul 2024

Registration expiry Date

27th Oct 2032

NEXT DX

Trademark usage description

providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequenc Read More

Classification Information


Class [042]
Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development.


Classification kind code

11

Class [044]
Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment.


Classification kind code

11

Mark Details


Serial Number

2225463

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 01st May 2024
Advertised
Submitted for opposition 26
on 03rd Apr 2024
Approved
Submitted for opposition 27
on 03rd Apr 2024
Approval Notice Sent
Submitted for opposition 22
on 26th Mar 2024
Search Recorded
Submitted for opposition 256
on 02th Oct 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 01st Dec 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 30th Nov 2022
Created
Submitted for opposition 31
on 30th Nov 2022
Formalized
Submitted for opposition 228
on 27th Oct 2022
International Registration
Submitted for opposition 30
on 27th Oct 2022
Filed